CTRI/2017/04/008306RecruitingPhase 1
Effect of Ushiradya Taila Matra Basti and Kanchanar Guggulu in the management of Mootraghata w.s.r to (Benign Prostatic Hyperplasia) An open labeled, randomized, comparative clinical trial
IPGT and RA GAU Jammagar GUJARAT0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Age 40 years to 70 years.
- •Patients having classical signs and symptoms of Mootraghata / BPH
Exclusion Criteria
- •Age below 40 years and above 70 years.
- •Patients of malignancy, congenital deformities of urogenital tract or any abdomino- pelvic pathology other than BPH.
- •Systemic diseases like Uncontrolled Hypertension and diabetes mellitus, Tuberculosis , Paralysis, Parkinsonism etc. will be excluded.
- •Known case of cardiac diseases.
Investigators
Similar Trials
Not yet recruiting
Unknown
Treatment of Benign Prostatic Hyperplasia using Kushaadi Taila Matra Basti (in the form of enema) and Gokshura Kwath ( to be taken freshly prepared orally by the patient)CTRI/2023/06/054495ttarakhand Ayurved University
Not yet recruiting
Phase 2
Medicated enema for improvement of quality of life in geriatric populatioCTRI/2023/07/054759Dr. Aastha Anup Thakar
Completed
Phase 4
Shilajatvadi Vati and Bala Taila Matra Basti in the management of MootraghataCTRI/2019/02/017868IPGT and RA Jamnagar30
Not yet recruiting
Phase 3
role of ayurveda in the management of lumbar spondylosisCTRI/2024/03/064682Institute of Teaching and Research in Ayurveda Jamnagar 361008
Recruiting
Phase 2
Effect of processed oil for nasal administratioCTRI/2023/02/049971Dr Alok Anand Jha